APA (7th ed.) Citation

T, Z., AL, P., R, N., DH, H., MC, B., JP, S., . . . M, S. (2022). Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial. Trials, 23(1), 57. https://doi.org/10.1186/s13063-021-05977-0

Chicago Style (17th ed.) Citation

T, Zeyen, et al. "Phase I/II Trial of Meclofenamate in Progressive MGMT-methylated Glioblastoma Under Temozolomide Second-line Therapy-the MecMeth/NOA-24 Trial." Trials 23, no. 1 (2022): 57. https://doi.org/10.1186/s13063-021-05977-0.

MLA (9th ed.) Citation

T, Zeyen, et al. "Phase I/II Trial of Meclofenamate in Progressive MGMT-methylated Glioblastoma Under Temozolomide Second-line Therapy-the MecMeth/NOA-24 Trial." Trials, vol. 23, no. 1, 2022, p. 57, https://doi.org/10.1186/s13063-021-05977-0.